首页 | 本学科首页   官方微博 | 高级检索  
     


Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease
Affiliation:1. Department of Physiology, College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230038, Anhui Province, China;2. The Third Clinical College of Zhejiang Chinese Medical University, Hangzhou 310005, Zhejiang Province, China;3. Department of Pharmacology, Shanghai Medical College of Fudan University, Shanghai 200032, China;4. Institute of Acupuncture and Meridian, College of Acupuncture and Osteology, Anhui University of Chinese Medicine, Hefei 230038, Anhui Province, China;1. School of Health Science Blanquerna, Ramon Llull University, Barcelona, Spain;2. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China;3. Faculty of Health Science and Welfare, University of Vic, Vic, Spain;4. Residència Jaume Batlle, Pere Mata Foundation, Barcelona, Spain;5. Global Research on Wellbeing (GRoW) Research Group, Ramon Llull University, Barcelona, Spain;1. Institute of Integrative Medicine, Faculty of Medicine, Witten/Herdecke University, 58313 Herdecke, Germany;2. Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China;1. Department of Pharmacology, Sinhgad Institute of Pharmacy, Narhe, Pune 411041, India;2. Department of Pharmacognosy, National Research Centre, Dokki, Giza 12411, Egypt;1. Drug Discovery Chemistry, Actelion Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland;2. Drug Discovery Pharmacology, Actelion Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland
Abstract:
Keywords:pulmonary disease, chronic obstructive  electroacupuncture  Point BL13 (Feishu)  Point ST36 (Zusanli)  orexin  anti-inflammation  rats
本文献已被 CNKI ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号